Hambrecht & Quist Capital Management
Latest statistics and disclosures from Tekla Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GILD, CELG, REGN, BIIB, ALXN. These five stock positions account for 36.93% of Tekla Capital Management's total stock portfolio.
- Added to shares of GILD (+$36.81M), AMGN (+$8.72M), Actavis (+$8.43M), FRX (+$5.57M), ONXX, ALXN, Warner Chilcott Plc -, Sagent Pharmaceuticals, AMRN, Merrimack Pharmaceuticals In.
- Started new stock positions in Merrimack Pharmaceuticals In, Actavis, Sagent Pharmaceuticals, SNTA, FRX.
- Reduced shares in these stocks: TMO (-$8.66M), CELG (-$8.45M), WPI (-$7.87M), CVD (-$7.80M), NBIX (-$6.54M), NPSP (-$5.92M), AGN (-$5.58M), REGN (-$5.48M), MYL, SHPGY.
- Sold out of its positions in FOLD, KERX, NPSP, TMO, WPI.
- As of March 31, 2013, Tekla Capital Management has $700.42M in assets under management (AUM). Assets under management grew from a total value of $625.91M to $700.42M.
- Independent of market fluctuations, Tekla Capital Management was a net buyer by $638515 worth of stocks in the most recent quarter.
Tekla Capital Management portfolio companies for quarter ending March 2013
| Ticker | Name | Portfolio Weight | Change | Share Count | Price | Last Trade |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences | 10.51 | +100.00% | 1504712 | 48.93 | 56.30 |
| CELG | Celgene Corporation | 8.44 | -12.00% | 510046 | 115.91 | 124.91 |
| REGN | Regeneron Pharmaceuticals | 7.05 | -9.00% | 279759 | 176.40 | 266.97 |
| BIIB | Biogen Idec | 6.04 | 219409 | 192.91 | 226.85 | |
| ALXN | Alexion Pharmaceuticals | 4.88 | +12.00% | 371329 | 92.14 | 102.90 |
| Puma Biotechnology Inc Common Stock | 4.79 | -9.00% | 1005667 | 33.39 | 0.00 | |
| PRGO | Perrigo Company | 3.43 | 202607 | 118.73 | 119.48 | |
| VRTX | Vertex Pharmaceuticals Incorporated | 2.98 | 379627 | 54.98 | 79.49 | |
| ONXX | Onyx Pharmaceuticals | 2.97 | +26.00% | 234456 | 88.86 | 95.65 |
| MYL | Mylan | 2.69 | -16.00% | 650954 | 28.94 | 31.40 |
| HOLX | Hologic | 2.62 | 813328 | 22.60 | 21.09 | |
| MRK | Merck & Co | 1.87 | 296620 | 44.23 | 45.99 | |
| AKRX | Akorn | 1.85 | 935758 | 13.83 | 14.50 | |
| CBST | Cubist Pharmaceuticals | 1.78 | 265972 | 46.82 | 49.51 | |
| TEVA | Teva Pharmaceutical Industries | 1.76 | 311476 | 39.68 | 40.23 | |
| SHPGY | Shire | 1.66 | -24.00% | 127053 | 91.36 | 0.00 |
| NBIX | Neurocrine Biosciences | 1.64 | -36.00% | 943987 | 12.14 | 11.75 |
| QCOR | Questcor Pharmaceuticals | 1.62 | -12.00% | 347856 | 32.54 | 37.34 |
| ARIA | Ariad Pharmaceuticals | 1.60 | 618620 | 18.09 | 16.67 | |
| Warner Chilcott Plc - | 1.51 | +33.00% | 782797 | 13.55 | 0.00 | |
| AET | Aetna | 1.44 | 197241 | 51.12 | 60.04 | |
| INCY | Incyte Corporation | 1.41 | 421300 | 23.41 | 23.04 | |
| MDVN | Medivation | 1.41 | -18.00% | 211399 | 46.77 | 47.53 |
| ENDP | Endo Pharmaceuticals | 1.40 | 318340 | 30.76 | 34.38 | |
| AMGN | Amgen | 1.39 | +850.00% | 95109 | 102.51 | 105.63 |
| ALR | Alere | 1.28 | 351726 | 25.53 | 26.30 | |
| Verastem | 1.22 | 884920 | 9.62 | 0.00 | ||
| Actavis | 1.20 | NEW | 91500 | 92.11 | 0.00 | |
| AMRN | Amarin Corporation | 1.13 | +35.00% | 1066498 | 7.41 | 7.14 |
| NKTR | Nektar Therapeutics | 1.06 | 674724 | 11.00 | 9.79 | |
| Alkermes | 1.06 | -25.00% | 312827 | 23.71 | 0.00 | |
| AGN | Allergan | 0.94 | -45.00% | 58700 | 111.64 | 101.41 |
| IMGN | ImmunoGen | 0.90 | 393773 | 16.06 | 16.29 | |
| ILMN | Illumina | 0.89 | 115379 | 54.00 | 72.00 | |
| MCK | McKesson Corporation | 0.88 | 56862 | 107.96 | 116.89 | |
| BAX | Baxter International | 0.81 | 77675 | 72.64 | 72.94 | |
| FRX | Forest Laboratories | 0.80 | NEW | 146500 | 38.04 | 38.53 |
| IPXL | Impax Laboratories | 0.76 | 344683 | 15.44 | 18.42 | |
| IDXX | IDEXX Laboratories | 0.74 | 56265 | 92.38 | 86.40 | |
| UNH | UnitedHealth | 0.67 | 82436 | 57.21 | 62.84 | |
| ACOR | Acorda Therapeutics | 0.66 | 144881 | 32.03 | 32.94 | |
| UTHR | United Therapeutics Corporation | 0.64 | 73210 | 60.87 | 69.17 | |
| CVS | CVS Caremark Corporation | 0.56 | 71591 | 54.99 | 59.44 | |
| IRWD | Ironwood Pharmaceuticals | 0.54 | 208287 | 18.29 | 14.39 | |
| EW | Edwards Lifesciences | 0.51 | -25.00% | 43650 | 82.15 | 67.06 |
| ARAY | Accuray Incorporated | 0.48 | +8.00% | 731943 | 4.64 | 5.26 |
| CRIS | Curis | 0.46 | 988471 | 3.28 | 4.12 | |
| Intellipharmaceuticsintl Inc C | 0.45 | 1735000 | 1.82 | 0.00 | ||
| VVUS | VIVUS | 0.41 | 262383 | 11.00 | 12.30 | |
| CVD | Covance | 0.37 | -75.00% | 35000 | 74.31 | 77.33 |
| Sagent Pharmaceuticals | 0.35 | NEW | 141126 | 17.55 | 0.00 | |
| DNDN | Dendreon Corporation | 0.25 | 376728 | 4.73 | 4.01 | |
| CLDX | Celldex Therapeutics | 0.23 | 140000 | 11.58 | 12.69 | |
| Ceres | 0.21 | 426481 | 3.48 | 0.00 | ||
| OGXI | OncoGenex Pharmaceuticals | 0.18 | 113100 | 11.33 | 10.50 | |
| SNTA | Synta Pharmaceuticals | 0.16 | NEW | 129000 | 8.60 | 7.50 |
| Merrimack Pharmaceuticals In | 0.16 | NEW | 184200 | 6.10 | 0.00 | |
| Endocyte | 0.11 | 60200 | 12.44 | 0.00 | ||
| CRTX | Cornerstone Therapeutics | 0.07 | 66112 | 7.06 | 9.00 | |
| Icad | 0.06 | +17.00% | 88527 | 4.99 | 0.00 | |
| Sanofi Aventis Wi Conval Rt | 0.03 | 103665 | 1.78 | 0.00 |
Past 13F-HR SEC Filings for Tekla Capital Management
- Tekla Capital Management 2012 Q4 - filed Feb. 1, 2013
- Tekla Capital Management 2012 Q3 - filed Oct. 19, 2012
- Tekla Capital Management 2012 Q2 - filed July 31, 2012
- Hambrecht & Quist Capital Management 2012 Q1 - filed May 8, 2012
- Hambrecht & Quist Capital Management 2011 Q4 - filed Feb. 3, 2012
- Hambrecht & Quist Capital Management 2011 Q3 - filed Nov. 14, 2011
- Hambrecht & Quist Capital Management 2011 Q2 - filed Aug. 12, 2011
- Hambrecht & Quist Capital Management 2011 Q1 - filed May 13, 2011
- Hambrecht & Quist Capital Management 2010 Q4 - filed Feb. 14, 2011